Urban Supreme System

Now that Changhua Pharmaceutical has acquired a new pharmaceutical factory, its production capacity has been greatly improved.

Moreover, Li Changhua has cooperated with new agents in several countries and signed supply contracts, and the demand for drugs has increased a lot.

Therefore, the production plan set before can no longer meet the current demand.

Therefore, Li Changhua set a new production plan based on the current actual situation to meet current demand.

In the attachment he sent, in addition to the sales report, there was also a new production plan and a list of agents he was currently working with.

The reason why Li Changhua made such a big move was because of Su Zhe.

Because Su Zhe told him a year ago that more and more therapeutic potions would be provided in the future, asking him to increase the production of Changhua Pharmaceutical in order to expand its scale.

That's why Li Changhua successively acquired large pharmaceutical companies and cooperated with agents in many countries. This recent series of events was all because of Su Zhe.

Of course, Su Zhe didn't ask Li Changhua to do this for no reason. After all, he had indeed refined a lot more healing potions now.

The previous plans were no longer suitable for the future, so he let Li Changhua go ahead and do it.

】∞ Now, Su Zhe is very satisfied with Li Changhua's efficiency.

Li Changhua's work efficiency is too high. He has done so many things in such a short period of time.

It can be seen from this that he has never taken a break and has been working non-stop to complete so many things.

The production plans of the five drugs currently launched by Changhua Pharmaceutical have been increased.

Before the improvement, the daily output of Thawsling was 23 million tablets. The daily output of mepsilin, refreshing tablets and blue elixir is 27 million tablets. The daily output of joint spirit is relatively high. The daily output has reached 38 million pieces.

Now that the output has been increased, the output of each drug has been greatly improved.

For example, the daily output of Thalysin has been increased from 23 million tablets to 35 million tablets, and the daily output of the other four drugs has been increased to 60 million tablets.

If Changhua Pharmaceutical had not acquired several large pharmaceutical companies,

Otherwise, such a high output plan will definitely not be able to meet production requirements.

and. After the production capacity is improved, it will be more than enough to produce these drugs.

Based on current production, Changhua Pharmaceutical consumes 750 barrels of therapeutic potions every month, with a total value of 30 billion yuan.

In fact, the increased production now is mainly provided to new agents and sent to markets in other countries for sale, while the domestic production plan has not changed much.

at present. Changhua Pharmaceutical's daily revenue in the domestic market has reached 220 million yuan. The net profit reached 35 million.

The daily revenue in foreign markets has reached 2.28 billion yuan, and the net profit has reached 1 billion yuan.

The daily revenue from the domestic market plus foreign markets totaled 2.5 billion yuan, and the net profit was 1.035 million yuan.

Although the production costs of Changhua Pharmaceutical are the same at home and abroad, because the domestic selling price is relatively low, the profit margin is also much lower.

The drugs sold by Changhua Pharmaceutical in foreign markets are sold at a price that is 50% higher than in the domestic market, so the profit margin is naturally much higher.

However, in general, Changhua Pharmaceutical’s drug prices are still on the low side.

If Changhua Pharmaceutical's five drugs were produced and sold by other pharmaceutical giants, sales and net profits might increase several times.

After all, the therapeutic effects of these drugs are so miraculous that many patients will need them.

In this case, even if the selling price is increased several times, ten times, or even a hundred times, there is no need to worry about not being able to sell it.

When the selling price increases, although the sales volume will decrease a little, the sales volume will increase a lot, not to mention the net profit.

However, Su Zhe didn't want to do this. After all, drugs and cosmetics are different.

Cosmetics are not necessities, they can be purchased according to one's own financial resources, so even if the snow cream and moisturizing cream are very profitable, he can still make a comfortable profit.

But medicine is different. Many people need life-saving help. If they can't afford medicine, they can only wait to die.

Therefore, Su Zhe would rather make less money than let the price be too high. He would set the price of all drugs at a level that is acceptable to most people.

In this case, the drugs produced by Changhua Pharmaceutical can save more people.

Moreover, Changhua Pharmaceutical's net profit reaches one billion yuan every day, which is actually not that small.

Su Zhe owns 85% of the shares of Changhua Pharmaceutical. Of the one billion yuan net profit, 850 million yuan belongs to him.

Moreover, he also sold a large amount of healing potions to Changhua Pharmaceutical, which can be exchanged for money.

Calculated based on the output of drugs, Changhua Pharmaceutical consumes 750 barrels of therapeutic potions every month, with a total value of 30 billion yuan.

In other words, he can get one billion yuan every day from the healing potion alone, plus 850 million yuan, which means that it can bring him 1.8 billion yuan and 50 million yuan in income every day.

Such a comparison shows that Changhua Pharmaceutical and Yadai Group actually earn almost the same amount of money for Su Zhe every day.

Moreover, the medicines sold by Changhua Pharmaceutical every day brought him a lot of points. If he didn't have points, he would have done a lot of things and wouldn't be able to refine the healing potion.

Therefore, if we seriously calculate it, Changhua Pharmaceutical still earns more, but it is not just money, there is a lot of value in it.

If Yadai Group and Changhua Pharmaceutical are calculated together, the daily income brought to Su Zhe reaches 2 billion yuan. If the daily consumption of potions is also included, it will be 3.8 billion yuan. Of course, this refers to Pre-tax income.

Moreover, except for therapeutic potions, neither Yadai Group nor Changhua Pharmaceutical has ever paid dividends.

Therefore, Su Zhe has not received a penny from these net profits. Not only him, but also shareholders such as Yan Yuyan and Shen Chuxia, as well as Liu Xiong and Li Changhua, have not received any money.

Because they have already agreed that the money earned will not be divided for now and will continue to be invested in expanding the scale of production in order to seek more benefits, so they have not divided the money yet.

For example, the money for Changhua Pharmaceutical's acquisition of many large pharmaceutical companies came from here.

After all, Su Zhe and the others did not invest any more money in the back, and could only take it from the profits.

Although Su Zhe didn't get any money, his net worth was constantly improving. It was just not that the bank deposits were increasing, but that there were more and more fixed assets.

If all assets were counted, his wealth would have already exceeded 100 billion. (To be continued...)

... ()